Sign Up to Receive Your Personalised Learning Resources
Start Learning
Supporting young haematologists: Insights on YoungEHA and EHA 24
Looking to the future in the treatment of steroid-refractory chronic GvHD
Insights from EHA and ISTH 2024: How can we optimize care for patients with chronic ITP?
Tailoring treatment in myelofibrosis: Addressing anaemia and thrombocytopenia
Durable clinical benefit with elritercept in lower-risk MDS: KER050-MD-201 trial
#ASH24: Discover the 2024 late-breaking abstracts
Very early FDG-PET/CT response-adapted therapy for advanced Hodgkin lymphoma
Racial differences in PFS and safety profiles in RVd vs. RVd+ASCT
A legacy in haematology: Prof. Robin Foà’s path from paediatrics to global impact
Optimizing treatment of CML in the first-line setting and beyond: Insights from EHA 2024 and ESH-iCMLf 2024
Sign up to view Favourites, Keep Notes and Track CME Credits
Favourites
Key highlights from ASH 2024: Promising new therapies for relapsed/refractory acute myeloid leukaemia
View
Targeting BCMA in multiple myeloma: Insights from COMy and EHA 2024
View
Positive phase III VERIFY study results for rusfertide in polycythemia vera
View
Empowering young haematologists: Insights from the EBMT Trainee Committee co-chairs
View
Looking to the future in the treatment of steroid-refractory chronic GvHD
View
Potential of elritercept (KER-050) to treat myelofibrosis: RESTORE trial
View
ATRA + ATO vs SoC in high-risk APL: APOLLO trial
View
Combination therapy in myelofibrosis: John Mascarenhas on the IMpactMF trial
View
EHA 2024: Highlights of the late-breaking abstracts
View
Multiple myeloma insights at EHA 2024
View
Log into your Touch Account
Earn and track your CME credits on the go, save articles for later, and follow the latest congress coverage.
Sign up with an Email
Or use a .
This Functionality is for
Members Only
Explore the latest in medical education and stay current in your field. Create a free account to track your learning.
